VELPATASVIR: 54 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
54
Total FAERS Reports
8 (14.8%)
Deaths Reported
9
Hospitalizations
54
As Primary/Secondary Suspect
First Report: 2017 · Latest Report: 20170202
What Are the Most Common VELPATASVIR Side Effects?
#1 Most Reported
Fatigue
15 reports (27.8%)
#2 Most Reported
Headache
12 reports (22.2%)
#3 Most Reported
Anaemia
12 reports (22.2%)
All VELPATASVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 15 | 27.8% | 4 | 2 |
| Anaemia | 12 | 22.2% | 4 | 0 |
| Headache | 12 | 22.2% | 4 | 1 |
| Nausea | 10 | 18.5% | 2 | 0 |
| Treatment failure | 10 | 18.5% | 0 | 0 |
| Hepatitis c | 9 | 16.7% | 0 | 0 |
| Pruritus | 9 | 16.7% | 1 | 0 |
| Insomnia | 8 | 14.8% | 1 | 1 |
| Hepatocellular carcinoma | 7 | 13.0% | 2 | 0 |
| Hyperbilirubinaemia | 7 | 13.0% | 3 | 0 |
| Alanine aminotransferase increased | 6 | 11.1% | 2 | 1 |
| Ascites | 6 | 11.1% | 2 | 1 |
| Asthenia | 6 | 11.1% | 2 | 0 |
| Hepatic failure | 6 | 11.1% | 3 | 0 |
| Abdominal pain | 5 | 9.3% | 1 | 1 |
| Arthralgia | 5 | 9.3% | 1 | 1 |
| Diarrhoea | 5 | 9.3% | 1 | 0 |
| Drug ineffective | 5 | 9.3% | 1 | 0 |
| Gastrointestinal haemorrhage | 5 | 9.3% | 1 | 0 |
| Rash | 5 | 9.3% | 1 | 1 |
Who Reports VELPATASVIR Side Effects? Age & Gender Data
Gender: 12.9% female, 87.1% male. Average age: 58.9 years. Most reports from: US. View detailed demographics →
Is VELPATASVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 2 | 0 | 1 |
What Is VELPATASVIR Used For?
| Indication | Reports |
|---|---|
| Chronic hepatitis c | 25 |
| Hepatitis c | 25 |
Official FDA Label for VELPATASVIR
Official prescribing information from the FDA-approved drug label.